2021
DOI: 10.1007/s00204-021-03028-w
|View full text |Cite
|
Sign up to set email alerts
|

Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
29
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 43 publications
(30 citation statements)
references
References 211 publications
0
29
0
1
Order By: Relevance
“…To date, a number of soil microbes have been demonstrated to produce MAs(III), either by MAs(V) reduction (Yoshinaga et al, 2011) or by methylation of As(III) (Qin et al, 2006). MAs(III) is highly toxic and has been shown to have antibiotic activity (Li et al, 2016;Styblo et al, 2021). Further methylation of MAs(III) to di-and trimethyl trivalent species may be protective if those species are rapidly oxidized or volatilized.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…To date, a number of soil microbes have been demonstrated to produce MAs(III), either by MAs(V) reduction (Yoshinaga et al, 2011) or by methylation of As(III) (Qin et al, 2006). MAs(III) is highly toxic and has been shown to have antibiotic activity (Li et al, 2016;Styblo et al, 2021). Further methylation of MAs(III) to di-and trimethyl trivalent species may be protective if those species are rapidly oxidized or volatilized.…”
Section: Discussionmentioning
confidence: 99%
“…The toxicity of arsenic highly depends on its species. Methylarsenite (MAs(III)), an intermediate product of arsenic biomethylation, is more toxic and potentially carcinogenic than either the corresponding pentavalent species or inorganic arsenite (As(III)), and may account for the majority of arsenic-related diseases (Yoshinaga-Sakurai et al, 2020;Li et al, 2021;Styblo et al, 2021). MAs(III) is stable in the anoxic environment that existed before the Great Oxidation Event (GOE) (Chen et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The capacity of arsenic methylation is a well-known modifier of arsenic-induced skin lesions, diabetes, and metabolic syndromes [ 28 , 29 , 30 , 31 ]. Inorganic arsenic (iAs) ingested from water and foods is metabolized to methylated arsenic species by arsenic (+3 oxidation state) methyltransferase (AS3MT), mainly in the liver in humans [ 32 , 33 ]. AS3MT methylates iAs to monomethylarsonic acid (MMA) in the first step and then to dimethylarsinic acid (DMA) in the second step.…”
Section: Introductionmentioning
confidence: 99%
“…Methylation of iAs to organic metabolites mainly functions as detoxification and elimination pathways of arsenic. However, arsenic methylation also produces highly toxic and unstable intermediates, as well as methylated trivalent forms of arsenic such as MMAs III and DMAs III [ 33 , 34 , 35 ]. Thus, arsenic methylation has dichotomous roles in the detoxification and metabolic activation of arsenic.…”
Section: Introductionmentioning
confidence: 99%